MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Primary Immune Thrombocytopenia

  1. Home
  2. Diseases
  3. Primary Immune Thrombocytopenia
  4. Clinical Trials

Clinical Trials Related to Primary Immune Thrombocytopenia

Related studies linked through entity extraction aliases.

NCT07710248

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

Status
RECRUITING
Phase
PHASE2

NCT07700238

A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Status
NOT_YET_RECRUITING
Phase
PHASE3

NCT07039422

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Status
RECRUITING
Phase
PHASE2

NCT05653219

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.